Top Markets
#1 Derive Derive +30.46%
#2 Cross Cross +14.21%
#3 Audiera Audiera +13.22%
#4 The Bitcoin Bull The Bitcoin Bull +10.65%
#5 Geodnet Geodnet +9.21%
#6 Gama Token Gama Token +9.19%
#7 Velvet Velvet +8.25%
#8 Biconomy Biconomy +8.17%
#9 Fake World Assets Fake World Assets +8.05%
#10 Palladium Network Palladium Network +7.97%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Clasificación en acciones #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Precio por acción
$0.05207079
Última sincronización: 2023-11-15
Capitalización bursátil
$3.38M
Cambio (1 día)
0.13%
Cambio (1 año)
0.00%
País
AU
Comercio Kazia Therapeutics Limited (KZA)

Categoría

Healthcare
EPS de Kazia Therapeutics Limited (KZA)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Kazia Therapeutics Limited, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Kazia Therapeutics Limited desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE